Lorelei A. Bandel

机构：MACOM (United States), Phoenix (United States) · ORCID：0009-0003-7146-0426

发表论文 12 篇 · 总被引 198 次 · h-index 6

代表论文

• Trastuzumab and tucatinib for the treatment of HER2 amplified metastatic colorectal cancer (mCRC): Initial results from the MOUNTAINEER trial (2019 · Annals of Oncology · 被引 93)
• Neurocognitive Effects of Repetitive Transcranial Magnetic Stimulation in Adolescents with Major Depressive Disorder (2013 · Frontiers in Psychiatry · 被引 44)
• A phase II, open label study of tucatinib (ONT-380) combined with trastuzumab in patients with HER2+ metastatic colorectal cancer (mCRC)(MOUNTAINEER). (2017 · Journal of Clinical Oncology · 被引 16)
• Mayo Clinic Tapestry Study (2024 · Mayo Clinic Proceedings · 被引 13)
• Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD) (2023 · Journal of Translational Medicine · 被引 12)
• Response to Repetitive Transcranial Magnetic Stimulation Induced Seizures in an Adolescent Patient With Major Depression: A Case Report (2013 · Brain stimulation · 被引 11)